Development of Monoclonal Antibody Therapeutics for Anthrax

Emergent Product Development Gaithersbur, Gaithersburg MD

Investigators

Abstract

This contract supports the advanced development of a therapeutic for the treatment of anthrax. The scope of work for this contract includes preclinical and clinical development activities that fall into the following areas: IND-enabling activities; manufacturing activities; animal study activities; and BLA-enabling activities.